Walleye Capital’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,306
Closed -$487K 2309
2022
Q2
$487K Buy
+2,306
New +$487K 0.01% 1025